Cartesian Therapeutics, Inc.

    Jurisdiction
    United States
    LEI
    529900NMN0LACZOL7C43
    ISIN
    US8162123025 (RNAC)
    Sectors
    1. Healthcare
    2. Biotechnology

    Scores

    InsiderPie Expert Score
    trending_flat 50 / 100
    Even with peer group:
    50 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    6 / 9

    Profile

    Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €883.95K
    Gross margin
    100.0%
    EBIT
    -€75.82M
    EBIT margin
    -8,577.6%
    Net income
    -€31.24M
    Net margin
    -3,534.1%

    Statement period: - (published )

    Dividends

    No dividend payouts

    Add to watchlist

    Notifications